StockWatch
·
JINDAL SAW LTD. · Q2 FY27 · THE VERDICT

A ₹17,000 Crore order book that can't pay the bills

Revenue climbed 5.6%, but net profit crashed 74.5%. The paradox—a deep order book, execution stumbling, margins eroded to near-breakeven—defines the quarter and confounds management's prior guidance.

Q2 FY27 resultsJINDALSAWJINDAL SAW LTD.22 Oct 2026 · 6 min read
Reported Revenue

₹4,472 Cr

+5.6% YoY, +0.4% QoQ

Reported PAT

₹35 Cr

-74.5% YoY, -61.1% QoQ

Net Profit Margin

0.8%

Down from 1.9% Q2 FY26

Order Backlog

₹17,000 Cr

Firm + LOI; 6L ton order delayed

On paper, Jindal Saw delivered revenue growth of 5.6% year-over-year to ₹4,472 crore. But the profit line tells a story of collapse: net profit fell to ₹35 crore from ₹139 crore a year ago, a 74.5% plunge. Net profit margin compressed to 0.8%—near breakeven—from 1.9% in the prior-year quarter. This is not a growth story by the headline. It's a margin crisis masked by a strong order book.

The gap: orders vs. execution

Management entered Q2 with a ₹17,000 crore order backlog—a figure investors naturally read as a growth catalyst. The largest order is a 6 lakh ton job work contract (value ~₹1,135 crore) from the MENA region. It was supposed to execute in Q2–Q3. Instead, Middle East escalations disrupted shipping and logistics. The order is now rescheduled to February–March 2027 onwards. That pushback alone explains why capacity utilization remains stuck at 67% versus a target of 80%.

But the execution drag is only part of the problem. The deeper issue is order quality. Of the ₹17,000 crore backlog, roughly 55–60% is job work—raw material supplied by the buyer, with Jindal capturing only the conversion margin. These are low-margin contracts. As Sailesh Raja from 360 ONE Capital pressed on the call, gross profit per kilogram has fallen to ₹41 from ₹51 in the prior year. That margin compression is the real story of Q2.

Why margins collapsed

EBITDA fell 22% quarter-over-quarter to ₹265 crore. The margin slide was driven by three structural headwinds:

  • Job-work dominance: majority of the order book is low-margin conversion work

  • Raw material and logistics inflation: coking coal costs spiked; global conflict driving shipping up; no pricing power in fixed-price contracts

  • Capacity underutilization: 67% effective utilization (2.3M tons of 3.5M design) means higher fixed costs per unit

Surging raw material costs, particularly for coking coal, have squeezed margins in the DI pipe business. This pressure was further compounded by lower capacity utilization due to lower execution in water pipe business as softness in domestic water business continues.

Management's claims vs. reality

What management promised; what Q2 delivered

H1 will show growth; H2 will be 'better' with improved volumes and margin recovery toward ₹51/kg gross profit

Q2 delivered

H1 delivered 13% revenue growth but PAT fell 59% YoY. Q2 PAT down 74.5%; GP/kg fell to ₹41, not recovering

Verdict

Overstated—near-term recovery not materializing

₹17,000 Cr order book will drive growth and profitability

Q2 delivered

Order book real but dominated by low-margin job work; largest order delayed to Feb-Mar 2027. Capacity utilization stuck at 67%

Verdict

Mixed—books are real, execution and margins both struggling

Abu Dhabi and Saudi plants will drive structural growth, commencing FY28-29

Q2 delivered

Capex on track. Abu Dhabi facility at ~50% utilization. Saudi JV acquiring land, no orders secured. 12+ months away

Verdict

Supported (long-term credible, not a near-term driver)

API license reinstatement in June 2026 will unlock higher-margin orders

Q2 delivered

License reinstated June 2026; bidding underway. Margin uplift deferred to 'coming quarters.' No Q2 evidence yet

Verdict

Supported (catalyst exists, benefit lagged)

What changed on this call

  • Margin outlook downgraded in reality: PAT fell 74.5% despite prior H2 improvement guidance

  • Largest order delayed: 6L ton MENA contract pushed from Q2-Q3 to Feb-Mar 2027; logistics crisis cited

  • MENA geopolitical risk elevated: ~30% of order exposure now flagged as disrupted; alternative logistics being explored

  • Capacity utilization gap widened: Abu Dhabi fell to ~50% utilization; supply chain and buyer logistics constraints cited

  • API license reinstatement a modest positive: bidding pipeline activated; margin upside deferred to H2–FY28

How the street is positioned

On the day of the result announcement, the stock fell 1.97% and closed below ₹280. That move is telling: the market validated the earnings miss rather than treated it as a buying opportunity. The stock is now trading at ₹249.6, down from an all-time high of ₹383.85, a drawdown of 35%. It trades below both its 50-day and 200-day simple moving averages (₹287.71 and ₹280.86, respectively), signaling weak technical momentum.

Foreign institutional investors are in retreat. FII ownership fell to 13.08% in Q1 FY27 from 13.46% a quarter earlier, a loss of 38 basis points. Meanwhile, domestic institutional ownership ticked up from 5.8% to 8.37%, a gain of 257 basis points. That reversal—foreigners selling, domestic buyers tentatively adding—suggests the market is bifurcated on the stock's outlook. Promoters remain entrenched at 63.25%, unchanged.

The sharp day-1 sell-off and the stock's position in the lower quartile of its 52-week range (trading at ₹249.6 versus a low of ₹153 and a high of ₹320) confirm that sentiment is cautious. The market is waiting for evidence of margin recovery, not just order book depth.

The bull-bear ledger

  • Large order book (₹17,000 Cr) is real and geographically diversified—CIS, Southeast Asia, MENA, domestic

  • Long-term capex (Abu Dhabi, Saudi) credible and on track for FY28-29 commencement

  • API license reinstatement unlocks higher-margin bidding pipeline

  • Net debt down ₹101 crore YTD; credit ratings stable (CARE A1+/AA)

  • PAT collapsed 74.5% YoY despite 5.6% revenue growth—profitability eroded to near-breakeven

  • Capacity utilization stuck at 67% versus 80% target despite large order backlog—execution bottleneck

  • 6L ton MENA order (largest contract) delayed to Feb-Mar 2027; geopolitical and logistics risks elevated

  • Gross profit per kg fell to ₹41 from ₹51; near-term recovery timeline vague; management hedged on H2 specifics

  • Job work dominance limits pricing power; buyer-supplied raw material reduces value capture

  • Domestic water pipes soft; Jal Jeevan Mission execution slow despite fund release

Risks, ranked by how much they should concern a holder

Key risks and consequences

Margin recovery remains unproven

HIGH

PAT collapsed 74.5% YoY. Management reaffirmed H2 improvement but was evasive on specifics ('things are volatile'). If H2 executes without margin lift, credibility collapses. Net profit is the number that moves valuations; revenue growth without profit growth is a trap.

MENA geopolitical disruption and logistics cost inflation

HIGH

~30% of order book exposed to MENA. Largest contract (6L tons) delayed to Feb-Mar 2027. Shipping costs spiked; global conflict shows no near-term relief. Further escalations could cascade delays and strand capacity.

Execution risk on ₹17,000 Cr order book

HIGH

Order book is real, but conversion bottlenecks are real too. Capacity at 67% despite large backlog. Buyer legal approvals (2–3 week lag post-LOI) and supply chain constraints limiting ramp. If execution slips beyond Feb-Mar 2027, fixed costs will consume remaining margin.

Job work margin structure and product mix

MEDIUM

55–60% of order book is low-margin job work (buyer-supplied raw material). GP/kg fell to ₹41. New oil & gas mix promised to improve margins, but timing uncertain. Until proven, assume NPM remains below 1%.

Capacity underutilization persists

MEDIUM

67% utilization (vs 80% target) means fixed costs per unit remain elevated. Abu Dhabi at ~50%. Until utilization reaches 75%+, unit economics will compress profitability into H1 FY28.

Litigation uncertainty (Jindal ITF vs NTPC)

LOW

Delhi High Court ruling expected January 2027. Outcome not quantified, but a loss could create unexpected liability. Minimal impact if win is assured, but uncertainty persists.

The debate

The honest read: Jindal Saw is caught between a real, deep order book and real execution/margin headwinds that are more than transitory. The company is not broken, but it is scrambling. Management entered Q2 expecting H1 improvement. They delivered the opposite. That miss—and the vagueness on H2 recovery—suggests management's visibility into near-term execution is limited. The order book will likely execute, but the margin tailwind from execution is not assured. Long-term capex (Abu Dhabi, Saudi) is credible and could unlock structural growth in FY28–FY29. But holders sitting today are betting that margin recovery happens by Q3 or Q4 FY27. That bet is uncertain at a 0.8% NPM.

What to watch next

The three concrete things that resolve the debate
  • 1 · MENA order execution and capacity utilization ramp (Feb-Mar 2027 onwards)

    Does the 6 lakh ton order actually dispatch on time? Does Abu Dhabi utilization recover above 60–70%? If execution slips again or utilization stays below 65%, margin recovery is off the table. This is the make-or-break catalyst for H2 FY27.

  • 2 · Gross profit per kg trajectory in Q3–Q4 FY27

    Does GP per kg stabilize above ₹45, or does it remain below ₹42? Margin recovery is not just a volume story; it's a product mix story (oil & gas vs. water pipes) and a cost story (raw material inflation, logistics). Track quarterly disclosures closely. This is the organic number that matters.

  • 3 · API order bidding traction and new oil & gas mix by year-end FY27

    Does management win any high-margin API orders? Does the oil & gas/export mix meaningfully displace the water pipe/job work concentration? No news by Q4 FY27 would suggest the API catalyst was overstated. Positive news would de-risk the margin recovery narrative.

Jindal Saw is not a growth story by the profit line right now. It's a company with a strong order book trying to prove it can execute profitably amid geopolitical disruption and cost inflation. The Q2 miss on margin (PAT −74.5%) despite revenue growth suggests that near-term operational leverage is not materializing. Management's hedged tone on H2 guidance, after missing H1 guidance, has eroded credibility.

This is not a sell-on-news scenario, because the order book is real and the long-term capex (Abu Dhabi, Saudi) could unlock structural growth. But it is a 'show me' moment. The stock needs to prove margin recovery in Q3–Q4 FY27 through either execution of higher-margin orders or cost stabilization. Until then, it trades as a cyclical value trap—cheap on revenue multiples, but not cheap enough to ignore the profit miss.

The single number to track from here is gross profit per kilogram. If it stabilizes above ₹45 in Q3–Q4 FY27, the bear case weakens. If it stays below ₹42, the recovery narrative is just that—a narrative.

Informational and educational content only. Not investment advice.